SLC27A5
(Solute Carrier Family 27 (Fatty Acid Transporter), Member 5 (SLC27A5))
Protein Region
Middle Region
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
Produktmerkmale
This is a synthetic peptide designed for use in combination with anti-SLC27A5 antibody (Catalog #: ARP41592_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Handhabung
Avoid repeated freeze-thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
SLC27A5
(Solute Carrier Family 27 (Fatty Acid Transporter), Member 5 (SLC27A5))
Synonyme
ACSB Peptide, ACSVL6 Peptide, BACS Peptide, BAL Peptide, FACVL3 Peptide, FATP-5 Peptide, FATP5 Peptide, VLACSR Peptide, VLCS-H2 Peptide, VLCSH2 Peptide, Vlacsr Peptide, rBAL-1 Peptide, SLC27A5 Peptide, solute carrier family 27 member 5 Peptide, solute carrier family 27 (fatty acid transporter), member 5 Peptide, bile acyl-CoA synthetase Peptide, SLC27A5 Peptide, Slc27a5 Peptide, LOC608675 Peptide, LOC100450572 Peptide
Hintergrund
The protein encoded by this gene is an isozyme of very long-chain acyl-CoA synthetase (VLCS). It is capable of activating very long-chain fatty-acids containing 24- and 26-carbons. It is expressed in liver and associated with endoplasmic reticulum but not